These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3590115)

  • 21. A survey of surface hemorheological experiments on the inhibition of fibrinogenin formation employing surface layers of fibrinogen systems with heparins and other substances. A contribution on antithrombogenic action.
    Copley AL; King RG
    Thromb Res; 1984 Aug; 35(3):237-56. PubMed ID: 6379981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and partial purification of a basic fibroblast growth factor-like growth factor derived from bovine colostrum.
    Hironaka T; Ohishi H; Masaki T
    J Dairy Sci; 1997 Mar; 80(3):488-95. PubMed ID: 9098798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue anticoagulants in the human placenta: preliminary study with a heparin-like anticoagulant and review of the literature.
    Uszyński M
    Gynecol Obstet Invest; 1991; 32(3):129-33. PubMed ID: 1836773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a low molecular weight form of epithelial transforming growth factor.
    Dunnington D; Prichett W; Moyer M; Greig R
    Life Sci; 1990; 47(22):2059-63. PubMed ID: 2273942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of fibrin clot formation by human serum amyloid P component (SAP) and heparin.
    Ku CS; Fiedel BA
    J Exp Med; 1983 Sep; 158(3):767-80. PubMed ID: 6886628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective double-blind comparison between Fragmin and conventional low-dose heparin: thromboprophylactic effect and bleeding complications.
    Bergqvist D; Burmark US; Frisell J; Hallböök T; Lindblad B; Risberg B; Törngren S; Wallin G
    Haemostasis; 1986; 16 Suppl 2():11-8. PubMed ID: 3744131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Participation of sialic acid residue in the fibrinogen-fibrin conversion by thrombin].
    Akihama S; Matsuda Y; Fukase T; Yamanaka A; Okude M
    Yakugaku Zasshi; 1995 Jul; 115(7):537-42. PubMed ID: 7562401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of the polypeptide chains involved in the cross-linking of fibrin.
    Chen R; Doolittle RF
    Proc Natl Acad Sci U S A; 1969 Jun; 63(2):420-7. PubMed ID: 5257132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the alpha C domains of fibrin in clot formation.
    Gorkun OV; Veklich YI; Medved LV; Henschen AH; Weisel JW
    Biochemistry; 1994 Jun; 33(22):6986-97. PubMed ID: 8204632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection and partial characterization of two bovine pregnancy-specific proteins.
    Butler JE; Hamilton WC; Sasser RG; Ruder CA; Hass GM; Williams RJ
    Biol Reprod; 1982 Jun; 26(5):925-33. PubMed ID: 6807365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant polypeptides derived from the fibrin binding domain of fibronectin are potential agents for the imaging of blood clots.
    Ezov N; Nimrod A; Parizada B; Werber MM; Goldlust A; Greenstein LA; Vogel T; Drizlich N; Levanon A; Reich S; Gorecki M; Panet A
    Thromb Haemost; 1997 Apr; 77(4):796-803. PubMed ID: 9134661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Future alternatives to heparin: low-molecular-weight heparin and hirudin.
    Donayre CE; Ouriel K; Rhee RY; Shortell CK
    J Vasc Surg; 1992 Apr; 15(4):675-82. PubMed ID: 1313932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in phosphatidylinositol phospholipase C isoenzymes and in their association with GTP gamma S-binding activity in guinea pig uterine smooth muscle during pregnancy.
    Wichelhaus DP; Jones CT
    J Dev Physiol; 1992 Aug; 18(2):49-58. PubMed ID: 1338954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro effects of pregnancy-associated plasma protein-A: artifacts due to heparin.
    Meisser A; Geinoz A; Bischof P
    Biol Reprod; 1988 Sep; 39(2):373-8. PubMed ID: 2460147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of heparin-binding endothelial mitogens by bovine uterine fibroblastic and epithelial cells.
    Johnson ML; Redmer DA; Reynolds LP
    Can J Physiol Pharmacol; 1996 Sep; 74(9):1079-86. PubMed ID: 8960401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.
    Harenberg J; Stehle G; Blauth M; Huck K; Mall K; Heene DL
    Semin Thromb Hemost; 1997; 23(1):83-90. PubMed ID: 9156415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Method for obtaining ovine uterine secretions from unilaterally pregnant ewes.
    Bazer FW; Roberts RM; Basha SM; Zavy MT; Caton D; Barron DH
    J Anim Sci; 1979 Dec; 49(6):1522-7. PubMed ID: 528437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits.
    Agnelli G; Pascucci C; Cosmi B; Nenci GG
    Thromb Haemost; 1990 Apr; 63(2):204-7. PubMed ID: 2363121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human placental anticoagulant protein: isolation and characterization.
    Funakoshi T; Heimark RL; Hendrickson LE; McMullen BA; Fujikawa K
    Biochemistry; 1987 Aug; 26(17):5572-8. PubMed ID: 2960376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model.
    Benedict CR; Ryan J; Wolitzky B; Ramos R; Gerlach M; Tijburg P; Stern D
    J Clin Invest; 1991 Nov; 88(5):1760-5. PubMed ID: 1939660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.